John Bryant
Impact in
- Cancer Research top 0.02%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
-
- American and British Literature Analysis 12
- Digital Humanities and Scholarship 12
- Literature: history, themes, analysis 10
-
- Homotopy and Cohomology in Algebraic Topology 18
- Co-authors
- Norman Wolmark (23 shared papers)Edwin R. Fisher (8 shared papers)Bernard Fisher (17 shared papers)Stewart Anderson (9 shared papers)Jong‐Hyeon Jeong (6 shared papers)Richard G. Margolese (5 shared papers)Donald Lawrence Wickerham (10 shared papers)Melvin Deutsch (5 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Leviathan (8 papers)Proceedings of the American Mathematical Society (7 papers)JNCI Journal of the National Cancer Institute (7 papers)American Literature (6 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
John Bryant
204 papers receiving 30.7k citations
John Bryant's Hit Papers
Peers
Comparison fields: 5 of 212
- Cancer Research 15.3k
- Oncology 10.8k
- Pathology and Forensic Medicine 3.5k
- Radiology, Nuclear Medicine and Imaging 2.6k
- Genetics 3.4k
Countries citing papers authored by John Bryant
This map shows the geographic impact of John Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Bryant more than expected).
Fields of papers citing papers by John Bryant
This network shows the impact of papers produced by John Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Bryant. The network helps show where John Bryant may publish in the future.
Co-authors
The 25 scholars most cited alongside John Bryant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 225 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer Hit paper breakdown → | 2004 | 4992 |
| 2 | Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer Hit paper breakdown → | 2002 | 4901 |
| 3 | Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer Hit paper breakdown → | 2005 | 4380 |
| 4 | Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer Hit paper breakdown → | 2006 | 2124 |
| 5 | Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. Hit paper breakdown → | 1998 | 1802 |
| 6 | Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation Hit paper breakdown → | 2002 | 1085 |
| 7 | Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials Hit paper breakdown → | 2017 | 844 |
| 8 | American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004 Hit paper breakdown → | 2004 | 814 |
| 9 | Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I Hit paper breakdown → | 2000 | 741 |
| 10 | 1996 | 726 | |
| 11 | Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31 Hit paper breakdown → | 2005 | 652 |
| 12 | 2005 | 565 | |
| 13 | erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer Hit paper breakdown → | 1998 | 559 |
| 14 | Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer Hit paper breakdown → | 1999 | 552 |
| 15 | 2002 | 497 | |
| 16 | 1997 | 419 | |
| 17 | 2019 | 348 | |
| 18 | 2002 | 339 | |
| 19 | Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient Hit paper breakdown → | 2020 | 334 |
| 20 | 2004 | 306 |
About John Bryant
John Bryant is a scholar working on Literature and Literary Theory, Mathematical Physics, Cancer Research, Geometry and Topology and Statistics and Probability, having authored 225 papers that have together received 32.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (27 papers), Pulsars and Gravitational Waves Research (18 papers), Homotopy and Cohomology in Algebraic Topology (18 papers), Topological and Geometric Data Analysis (17 papers), American and British Literature Analysis (12 papers), Digital Humanities and Scholarship (12 papers), Geometric and Algebraic Topology (11 papers) and Literature: history, themes, analysis (10 papers). The work is most often cited by research in Cancer Research (15.3k citations), Oncology (10.8k citations), Pathology and Forensic Medicine (3.5k citations), Radiology, Nuclear Medicine and Imaging (2.6k citations) and Genetics (3.4k citations). John Bryant has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Norman Wolmark, Edwin R. Fisher, Bernard Fisher, Stewart Anderson, Jong‐Hyeon Jeong, Richard G. Margolese, Donald Lawrence Wickerham, Melvin Deutsch, Soonmyung Paik and Gong Tang. Their work appears in journals such as Journal of Clinical Oncology, Leviathan, Proceedings of the American Mathematical Society, JNCI Journal of the National Cancer Institute and American Literature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.